Yoshino Akira fixes the basic structure of the lithium-ion battery, and the patents that follow (1985)
The value of keeping hold of a technology’s origin
The core of this decision lies not in a business strategy settled at a management meeting but in a technical choice made by a single researcher inside the basic-research themes he was reassigned every two years. Choosing a carbon material for the anode was not, at the time, understood as a managerial move that would decide whether the battery could be mass-produced or commercialised at all. Yet it is precisely this technical judgment that became the asset which survived the rises and falls of Asahi Kasei’s battery business over the following three decades and more.
The implication of the case is that, having taken the setback of a dissolved joint venture on the mass-production side, the company nonetheless kept hold of an intangible asset — the basic patents — and that this bore fruit in the 2019 Nobel Prize in Chemistry. Even when outrun by competitors in the speed of commercialisation, holding on to the origin of a technology has a value of its own. With the development race over all-solid-state batteries entering a new phase, Yoshino’s own question — how to position sustained investment in basic research — still carries weight, and not for Asahi Kasei alone.
Revenue and net margin, FY1980–FY1990
Revenue in ¥ bn (bars) and net margin in % (line), for the years around the decision. Shaded columns are FY1985 onwards — after it was taken.
Source: securities reports
Read the full dossier in Japanese →
The Japanese edition carries the complete record of this decision — the situation that forced it, the options weighed, what actually followed, and the sources behind every claim.
Other key decisions at Asahi Kasei
- 1946 Splitting from the Nichitsu konzern to become Asahi Kasei Kogyo (1946)
- 1961 Miyazaki Teru takes the presidency and makes the “healthy loss-making division” the axis of diversification (1961)
- 1968 The ¥100 billion petrochemical complex at Mizushima — a sum equal to a year of sales (1968)
- 1972 Turning the ALC building material Hebel into a housing brand (1972)
- 1993 Turning away from “expansion”: selling the food and liquor businesses (1993)
- 2012 Buying ZOLL Medical for $2.21 billion and entering critical care (2012)
Yen amounts are converted at the average rate of each figure’s own year — not today’s rate; the revenue chart is shown in yen. Exchange rates & sources — the full ¥/US$ table →
Disclaimer
- This page is provided for general information only and is not investment advice, nor a recommendation to buy or sell any security.
- Figures are compiled independently and include our own estimates, approximations and machine-processed data; we make no warranty as to their accuracy or completeness.
- Sources are primarily each company’s securities reports and other public filings, but errors and omissions may remain.
- Any use of this information is at the reader’s own risk. Past performance does not indicate future results.
- Company names, logos and other marks belong to their respective owners.
Data API
Asahi Kasei’s history, financials, executives and
shareholders are published as static JSON — no key, plain GET.
Full specification →
| Method | Endpoint | Returns |
|---|---|---|
| GET | /api/companies.json | All companies |
| GET | /api/3407/manifest.json | Resource index |
| GET | /api/3407/history.json | History overview |
| GET | /api/3407/timeline.json | Chronology |
| GET | /api/decisions.json | All management decisions (index) |
| GET | /api/3407/decisions.json | Management decisions (index) |
| GET | /api/3407/decisions/{slug}.json | One decision (full dossier) |
| GET | /api/3407/executives.json | Executives |
| GET | /api/3407/shareholders.json | Major shareholders |
| GET | /api/3407/financials.json | Financial statements |
| GET | /api/3407/financials-longterm.json | Long-term results |
| GET | /api/3407/segments.json | Business segments |
| GET | /api/3407/regions.json | Sales by region |
| GET | /api/3407/workforce.json | Workforce |